Neil Chatterji Stock Analyst Profile - B. Riley Securities Research Coverage - Stocknear

Neil Chatterji

Stock Analyst at B. Riley Securities

(3.51)
# 2663
Out of 5,506 analysts
26
Total ratings
Success rate
Average return

12 Stocks

Name Action PT Current % Upside Ratings Updated
CLPT ClearPoint Neuro
Maintains: Strong Buy
20 28
27.38 2.26% 4 Apr 25, 2025
OPRX OptimizeRx
Maintains: Buy
17 13
18.75 -30.67% 3 Dec 24, 2024
AUGX Augmedix
Reinstates: Buy
6
n/a n/a 3 Apr 3, 2024
ESTA Establishment Labs H...
Maintains: Buy
95 50
41.43 20.69% 2 Nov 9, 2023
SILK Silk Road Medical
Downgrades: Neutral
54 14
n/a n/a 3 Oct 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
8
1.69 343.79% 1 Oct 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
15 18
20.02 -10.09% 2 Sep 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
5
3.85 16.88% 1 Sep 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
3 4
1.48 136.49% 3 Aug 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
6 6
3.13 75.72% 2 Mar 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
32
n/a n/a 1 Dec 14, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
10
2.33 307.73% 1 Oct 4, 2022